Interestingly, AML cells (primary cells and cell lines) expressing CaMKIV show elevated levels of Cdk inhibitors p27 (kip1) and p16 (ink4a) and reduced levels of cyclins A, B1, and D1. Here, CDKN1B is linked to acute myeloid leukemia.